Evidence map›Paper›PMID 34289374›Full record

ArticleCell reports2021

Lin28 paralogs regulate lung branching morphogenesis.

Jihan K Osborne, Melissa A Kinney, Areum Han, Kemi E Akinnola, Alena V Yermalovich, Linda T Vo, Daniel S Pearson, Patricia M Sousa, Sutheera Ratanasirintrawoot, Kaloyan M Tsanov and 4 more

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.5field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Nephron-SpecificInternational journal of biological sciences · 2024
    Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Jihan K OsborneDivision of Pediatric Hematology/Oncology, Boston Children's Hospital Boston, MA 02115, USA; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA.
Melissa A KinneyDivision of Pediatric Hematology/Oncology, Boston Children's Hospital Boston, MA 02115, USA; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA.
Areum HanDivision of Pediatric Hematology/Oncology, Boston Children's Hospital Boston, MA 02115, USA; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA.
Kemi E AkinnolaDivision of Pediatric Hematology/Oncology, Boston Children's Hospital Boston, MA 02115, USA; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA.
Alena V YermalovichDivision of Pediatric Hematology/Oncology, Boston Children's Hospital Boston, MA 02115, USA; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA.
Linda T VoDivision of Pediatric Hematology/Oncology, Boston Children's Hospital Boston, MA 02115, USA; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA.
Daniel S PearsonDivision of Pediatric Hematology/Oncology, Boston Children's Hospital Boston, MA 02115, USA; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA.
Patricia M SousaDivision of Pediatric Hematology/Oncology, Boston Children's Hospital Boston, MA 02115, USA.
Sutheera RatanasirintrawootDivision of Pediatric Hematology/Oncology, Boston Children's Hospital Boston, MA 02115, USA; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA.
Kaloyan M TsanovDivision of Pediatric Hematology/Oncology, Boston Children's Hospital Boston, MA 02115, USA; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA.
Jessica BarraganDivision of Pediatric Hematology/Oncology, Boston Children's Hospital Boston, MA 02115, USA.
Trista E NorthDivision of Pediatric Hematology/Oncology, Boston Children's Hospital Boston, MA 02115, USA.
Ross J MetzgerDepartment of Pediatrics (Cardiology), Stanford University School of Medicine, Stanford, CA 94305, USA.
George Q DaleyDivision of Pediatric Hematology/Oncology, Boston Children's Hospital Boston, MA 02115, USA; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA. Electronic address: george.daley@childrens.harvard.edu.
Harvard University · USBoston Children's Hospital · USStanford University · US

Funding

Understanding the role of the lin28 paralogs and branching morphogenesisR01GM107536 · NIGMS · BOSTON CHILDREN'S HOSPITAL · PI DALEY, GEORGE Q · 2014 to 2017
$1.9M
The role of Lin28/let 7 pathway in Wilms' tumorF99CA212487 · NCI · HARVARD UNIVERSITY · PI YERMALOVICH, ALENA · 2016 to 2017
$65k
Howard Hughes Medical InstituteNCI NIH HHS F99 CA212487NIGMS NIH HHS R01 GM107536
6 · The paper itself

Abstract

The molecular mechanisms that govern the choreographed timing of organ development remain poorly understood. Our investigation of the role of the Lin28a and Lin28b paralogs during the developmental process of branching morphogenesis establishes that dysregulation of Lin28a/b leads to abnormal branching morphogenesis in the lung and other tissues. Additionally, we find that the Lin28 paralogs, which regulate post-transcriptional processing of both mRNAs and microRNAs (miRNAs), predominantly control mRNAs during the initial phases of lung organogenesis. Target mRNAs include Sox2, Sox9, and Etv5, which coordinate lung development and differentiation. Moreover, we find that functional interactions between Lin28a and Sox9 are capable of bypassing branching defects in Lin28a/b mutant lungs. Here, we identify Lin28a and Lin28b as regulators of early embryonic lung development, highlighting the importance of the timing of post-transcriptional regulation of both miRNAs and mRNAs at distinct stages of organogenesis.

Indexed as

MorphogenesisSequence Homology, Amino AcidEmbryo, MammalianFeedback, PhysiologicalFibroblast Growth Factor 10Gene Expression Regulation, DevelopmentalHedgehog ProteinsHEK293 CellsHumansLungMicroRNAsModels, BiologicalRNA-Binding ProteinsSignal TransductionSOX9 Transcription FactorFibroblast Growth Factor 10Hedgehog ProteinsLin28b protein, mouseLin-28 protein, mouseMicroRNAsmirnlet7 microRNA, mouseRNA-Binding ProteinsSOX9 Transcription Factorbranching morphogenesisLin28a/Lin28blung developmentpost-transcriptional regulation

Identifiers

PMID34289374
PMCPMC8371695
OpenAlexW3185623841

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.